Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. (Q39105491)

9 September 2017

title

Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. (English)

1 reference

9 September 2017

1 reference

1 reference

1 reference

Yuqi Wang

1 reference

9 September 2017

Weimin Dai

1 reference

9 September 2017

Xiangyang Chu

1 reference

9 September 2017

Bo Yang

1 reference

9 September 2017

Ming Zhao

1 reference

9 September 2017

Yu'e Sun

1 reference

9 September 2017

publication date

24 August 2013

1 reference

9 September 2017

published in

Biotechnology Letters

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

2013-2019

1 reference

Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Diabetes: preventing type 2 diabetes mellitus: is metformin the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

miR-221/222: promising biomarkers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Mechanistic links between COPD and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

MicroRNAs 221 and 222 bypass quiescence and compromise cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Prevention of pancreatic cancer induction in hamsters by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

microRNA-222 targeting PTEN promotes neurite outgrowth from adult dorsal root ganglion neurons following sciatic nerve transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-013-1309-0

10.1007/S10529-013-1309-0

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference